NEURONETICS, INC. financials

STIM CIK 0001227636

Source: EDGAR filings · Built 2026-06-02T04:06:37Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -21.20M -32.46M -34.41M -34.01M -30.34M -29.12M
EBITDA -27.97M -32.49M -28.55M -33.46M -26.50M -21.37M
Working Capital 31.03M 26.86M 73.98M 65.57M 99.63M 51.33M
Net Debt 62.17M 64.17M 2.80M -30.59M -54.60M -10.62M
Gross Margin 48.48% 72.32% 72.47% 76.26% 78.93% 76.54%
Operating Margin -21.08% -46.15% -42.82% -53.85% -49.83% -45.30%
Net Margin -26.15% -58.36% -42.31% -56.99% -56.39% -55.75%
Return on Equity (ROE) -174.27% -157.76% -88.30% -65.12% -36.62% -107.69%
Return on Assets (ROA) -27.55% -31.02% -26.06% -31.79% -22.09% -34.90%
Current Ratio 2.02× 1.86× 4.73× 2.98× 7.34× 4.75×
Debt-to-Equity 4.04× 2.98× 1.83× 0.70× 0.46× 1.50×
Cash Conversion Ratio 0.52× 0.71× 1.06× 0.83× 0.90× 1.03×
Accruals Ratio -0.13× -0.09× 0.02× -0.05× -0.02× 0.01×
SBC % of Revenue 4.59% 7.48% 10.26% 13.41% 14.23% 8.94%
CapEx Coverage -25.47× -21.14× -13.52× -9.40× -11.89× -38.89×
Free Cash Flow Per Share $-0.32 $-1.02 $-1.20 $-1.26 $-1.19 $-1.55

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/S 0.64× 1.20× 1.18× 2.87× 2.13× 4.31×
P/B 4.25× 3.24× 2.47× 3.28× 1.38× 8.33×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 149.16M 74.89M 71.35M 65.21M 55.31M 49.24M
Revenues 15.58M
Cost of Goods and Services Sold 76.85M 20.73M 19.64M 15.48M 11.65M 11.55M
Cost of Revenue 3.76M
Gross Profit 72.31M 54.16M 51.70M 49.72M 43.66M 37.69M
Research and Development Expense 6.58M 12.77M 9.52M 9.34M 7.92M 9.20M
Operating Expenses 103.74M 88.72M 82.26M 84.83M 71.22M 60.00M
Operating Income (Loss) -31.44M -34.56M -30.55M -35.11M -27.56M -22.31M
Net Income (Loss) Attributable to Parent -39.00M -43.71M -30.19M -37.16M -31.19M -27.45M
Earnings Per Share, Basic $-0.59 $-1.38 $-1.05 $-1.38 $-1.22 $-1.46
Weighted Average Number of Shares Outstanding, Basic 65.95M 31.73M 28.66M 26.90M 25.48M 18.84M
Earnings Per Share, Diluted $-0.59 $-1.38 $-1.05 $-1.38 $-1.22 $-1.46
Weighted Average Number of Shares Outstanding, Diluted 65.95M 31.73M 28.66M 26.90M 25.48M 18.84M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 28.13M 18.46M 59.68M 70.34M 94.14M 48.96M
Assets, Current 61.55M 58.12M 93.79M 98.77M 115.33M 65.01M
Assets 141.55M 140.90M 115.83M 116.88M 141.22M 78.66M
Long-term Debt 65.81M 55.15M 59.28M 35.95M 35.34M 34.62M
Liabilities, Current 30.52M 31.27M 19.81M 33.20M 15.70M 13.68M
Long-term Debt, Excluding Current Maturities 65.81M 55.15M 59.28M 22.83M 35.34M 34.62M
Liabilities 115.31M 109.10M 81.64M 59.82M 56.05M 53.16M
Stockholders' Equity Attributable to Parent 22.38M 27.71M 34.19M 57.06M 85.17M 25.49M
Common Stock, Shares, Outstanding 68.99M 55.68M 29.09M 27.27M 26.39M 19.11M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -20.40M -31.00M -32.04M -30.74M -27.98M -28.39M
Net Cash Provided by (Used in) Investing Activities -801.00K -2.41M -1.32M 6.73M -9.84M -730.00K
Net Cash Provided by (Used in) Financing Activities 35.85M -6.81M 22.70M 207.00K 83.01M 2.37M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (STIM CIK 0001227636), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

UTMD

UTAH MEDICAL PRODUCTS INC

DE

DEERE & CO

MTB

M&T BANK CORPORATION